Description

4-Oxo-4-(3-Oxopiperazin-1-Yl)-n-[(2E)-4,5,6,7-Tetrahydro-1,3-Benzothiazol-2(3H)-Ylidene]Butanamide is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is of significant value for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular scaffolds. It is primarily sought by research institutions and pharmaceutical manufacturers engaged in the development of new drug candidates, especially within oncology and central nervous system (CNS) research.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of novel small-molecule drug candidates.
• Oncology Research: Used in the development of targeted cancer therapies due to its specific molecular architecture.
• CNS Drug Discovery: Serves as a building block for compounds targeting neurological disorders.
• Chemical Biology: Employed as a probe or tool compound in biochemical and pharmacological studies.
• Process Chemistry & Scale-up: Utilized in route scouting and optimization for API manufacturing under GMP conditions.
• Contract Research & Development (CRO/CMO): Supplied to organizations specializing in custom synthesis and development services.

Basic Information

Product Name	4-Oxo-4-(3-Oxopiperazin-1-Yl)-n-[(2E)-4,5,6,7-Tetrahydro-1,3-Benzothiazol-2(3H)-Ylidene]Butanamide
CAS No.	1219549-97-9
Molecular Formula	C17H21N5O3S
Molecular Weight	375.45 g/mol
Synonyms	4-(3-Oxopiperazin-1-yl)-4-oxo-N-[(2E)-4,5,6,7-tetrahydro-1,3-benzothiazol-2(3H)-ylidene]butanamide; 4-Oxo-4-(3-oxo-1-piperazinyl)-N-[(2E)-4,5,6,7-tetrahydro-2-benzothiazolylidene]butanamide; Butanamide, 4-oxo-4-(3-oxo-1-piperazinyl)-N-[(2E)-4,5,6,7-tetrahydro-2-benzothiazolylidene]-; (2E)-2-({[4-(3-Oxopiperazin-1-yl)-4-oxobutanoyl]imino})-4,5,6,7-tetrahydro-1,3-benzothiazol-3-ium-3-ide
EINECS	Contact for details

Quality Control

Our 4-Oxo-4-(3-Oxopiperazin-1-Yl)-n-[(2E)-4,5,6,7-Tetrahydro-1,3-Benzothiazol-2(3H)-Ylidene]Butanamide is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, MS). Certificates of Analysis (COA) detailing batch-specific results are provided to ensure traceability and compliance with your research or development protocols.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). This material is moisture-sensitive; keep the container tightly sealed in a dry environment. For long-term storage, consider inert atmosphere conditions to maintain optimal stability.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference standard
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.